Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.
Porter A, Akbari A, Carson-Stevens A, Dale J, Dixon L, Edwards A, Evans B, Griffiths L, John A, Jolles S, Kingston MR, Lyons R, Morgan J, Sewell B, Whiffen A, Williams VA, Snooks H. Porter A, et al. Among authors: jolles s. BMJ Open. 2023 Aug 4;13(8):e073464. doi: 10.1136/bmjopen-2023-073464. BMJ Open. 2023. PMID: 37541747 Free PMC article. Review.
Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
Evans BA, Akbari A, Bailey R, Bethell L, Bufton S, Carson-Stevens A, Dixon L, Edwards A, John A, Jolles S, Kingston MR, Lyons J, Lyons R, Porter A, Sewell B, Thornton CA, Watkins A, Whiffen T, Snooks H. Evans BA, et al. Among authors: jolles s. BMJ Open. 2022 Sep 8;12(9):e059813. doi: 10.1136/bmjopen-2021-059813. BMJ Open. 2022. PMID: 36691218 Free PMC article.
Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
Snooks H, Watkins A, Lyons J, Akbari A, Bailey R, Bethell L, Carson-Stevens A, Edwards A, Emery H, Evans BA, Jolles S, John A, Kingston M, Porter A, Sewell B, Williams V, Lyons RA. Snooks H, et al. Among authors: jolles s. Public Health. 2023 May;218:12-20. doi: 10.1016/j.puhe.2023.02.008. Epub 2023 Feb 15. Public Health. 2023. PMID: 36933354 Free PMC article.
Corrigendum to "Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in wales? Results of EVITE immunity, a linked data retrospective study" [Public Health 218 (2023) 12-20].
Snooks H, Watkins A, Lyons J, Akbari A, Bailey R, Bethell L, Carson-Stevens A, Dale J, Edwards A, Emery H, Evans BA, Jolles S, John A, Kingston M, Porter A, Sewell B, Williams V, Lyons RA. Snooks H, et al. Among authors: jolles s. Public Health. 2023 Sep;222:229. doi: 10.1016/j.puhe.2023.06.001. Epub 2023 Jul 16. Public Health. 2023. PMID: 37463828 Free PMC article. No abstract available.
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, Zhang Z, Farmery JHR, Simeoni I, Rivers E, Maimaris J, Penkett CJ, Stephens J, Deevi SVV, Sanchis-Juan A, Gleadall NS, Thomas MJ, Sargur RB, Gordins P, Baxendale HE, Brown M, Tuijnenburg P, Worth A, Hanson S, Linger RJ, Buckland MS, Rayner-Matthews PJ, Gilmour KC, Samarghitean C, Seneviratne SL, Sansom DM, Lynch AG, Megy K, Ellinghaus E, Ellinghaus D, Jorgensen SF, Karlsen TH, Stirrups KE, Cutler AJ, Kumararatne DS, Chandra A, Edgar JDM, Herwadkar A, Cooper N, Grigoriadou S, Huissoon AP, Goddard S, Jolles S, Schuetz C, Boschann F; Primary Immunodeficiency Consortium for the NIHR Bioresource; Lyons PA, Hurles ME, Savic S, Burns SO, Kuijpers TW, Turro E, Ouwehand WH, Thrasher AJ, Smith KGC. Thaventhiran JED, et al. Among authors: jolles s. Nature. 2020 Aug;584(7819):E2. doi: 10.1038/s41586-020-2556-6. Nature. 2020. PMID: 32678341
The cost of implementing the COVID-19 shielding policy in Wales.
Sewell B, Farr A, Akbari A, Carson-Stevens A, Dale J, Edwards A, Evans BA, John A, Torabi F, Jolles S, Kingston M, Lyons J, Lyons RA, Porter A, Watkins A, Williams V, Snooks H. Sewell B, et al. Among authors: jolles s. BMC Public Health. 2023 Nov 26;23(1):2342. doi: 10.1186/s12889-023-17169-3. BMC Public Health. 2023. PMID: 38008730 Free PMC article.
Changes in immunoglobulin levels during clozapine treatment in schizophrenia.
Griffiths K, Mellado MR, Chung R, Lally J, McQueen G, Sendt KV, Gillespie A, Ibrahim M, Richter A, Shields A, Ponsford M, Jolles S, Hodsoll J, Pollak TA, Upthegrove R, Egerton A, MacCabe JH. Griffiths K, et al. Among authors: jolles s. Brain Behav Immun. 2024 Jan;115:223-228. doi: 10.1016/j.bbi.2023.10.001. Epub 2023 Oct 11. Brain Behav Immun. 2024. PMID: 37832895
Phenotypic Variability in PRKCD: a Review of the Literature.
Jefferson L, Ramanan AV, Jolles S, Bernatoniene J, Mathieu AL, Belot A, Roderick MR. Jefferson L, et al. Among authors: jolles s. J Clin Immunol. 2023 Nov;43(8):1692-1705. doi: 10.1007/s10875-023-01579-4. Epub 2023 Oct 5. J Clin Immunol. 2023. PMID: 37794137 Review.
242 results